← All stocks

Amgen

AMGN Net selling
CIK 0000318154 #40 in the set updated 17 Sep 2026
Bought (120 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$93.94M
$0.00 on a plan · $51.92M straight out of an exercise
Sold at will
$42.03M
47 of 86 sales
Net
−$93.94M
−$42.03M against sales at will

By person

40 insiders · 96 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Santos Esteban
EVP, Operations
$23.32M (3) scheduled
−$23.32M
82,847
0.0153%
$34.50M
+176.6%
Graham Jonathan P
EVP & Gen. Counsel & Sec.
$18.04M (5)
−$18.04M
39,712
0.0073%
$16.54M
−25.1%
REESE DAVID M
EVP & Chief Technology Officer
$10.23M (2)
−$10.23M
42,256
0.0078%
$17.60M
+69.0%
Gordon Murdo
EVP, Global Commercial Ops
$7.41M (3)
−$7.41M
51,222
0.0095%
$21.33M
+945.1%
SUGAR RONALD D
Director
$6.22M (20) scheduled
−$6.22M
19,682
0.0036%
$8.20M
+54.7%
Grygiel Nancy A.
SVP & CCO
$5.54M (11) scheduled
−$5.54M
7,340
0.0014%
$3.06M
+67.6%
Jacks Tyler
Director
$3.91M (1) scheduled
−$3.91M
18,284
0.0034%
$7.61M
+100.3%
Patton Cynthia M
SVP & CCO
$3.61M (5) scheduled
−$3.61M
24,751
0.0046%
$10.31M
+10.7%
Harper Sean E
EVP, Research & Development
$2.76M (10)
−$2.76M
56,082
0.0104%
$23.35M
+17.4%
Khosla Rachna
SVP, Business Development
$2.19M (5)
−$2.19M
6,404
0.0012%
$2.67M
+41.2%
Miller Derek
SVP, Human Resources
$2.16M (4) scheduled
−$2.16M
12,462
0.0023%
$5.19M
+99.8%
Piacquad David
SVP, Business Development
$2.13M (1)
−$2.13M
44,787
0.0083%
$18.65M
+15.3%
Meline David W
EVP & CFO
$2.05M (1)
−$2.05M
49,378
0.0091%
$20.56M
+2.9%
ECKERT ROBERT
Director
$1.64M (1)
−$1.64M
26,251
0.0049%
$10.93M
+150.3%
Williams R Sanders
Director
$813.32K (10)
−$813.32K
6,240
0.0012%
$2.60M
+124.5%
de Carbonnel Francois
Director
$694.42K (1)
−$694.42K
16,426
0.0030%
$6.84M
−12.0%
Busch Matthew C.
VP, Finance & CAO
$655.48K (2)
−$655.48K
5,080
0.0009%
$2.12M
+6.8%
BALTIMORE DAVID
Director
$569.54K (1)
−$569.54K
32,286
0.0060%
$13.44M
−4.0%
Bradway Robert A
Chairman, CEO and President
595,160
0.1101%
$247.84M
+91.4%
HOOPER ANTHONY C
EVP, Global Commercial Ops.
215,147
0.0398%
$89.59M
+13.0%
MCNAMEE BRIAN M
EVP
102,516
0.0190%
$42.69M
+10.9%
Griffith Peter H.
EVP & CFO
50,150
0.0093%
$20.88M
+122.3%
Johnston Lori A
EVP, HR
40,881
0.0076%
$17.02M
+300.0%
BIONDI FRANK
Director
36,635
0.0068%
$15.26M
+3.5%
HERRINGER FRANK C
Director
35,522
0.0066%
$14.79M
+10.9%
Bradner James E.
EVP, Research and Development
30,016
0.0056%
$12.50M
+1,539%
HENDERSON REBECCA M
Director
17,974
0.0033%
$7.48M
+56.3%
Kullman Ellen Jamison
Director
14,536
0.0027%
$6.05M
+568.0%
Garland Greg C.
Director
13,848
0.0026%
$5.77M
+195.0%
HOLLEY CHARLES M
Director
12,990
0.0024%
$5.41M
+2,978%
PELHAM JUDITH C
Director
11,232
0.0021%
$4.68M
+12.3%
Louie Linda H.
VP, Finance & CAO
9,966
0.0018%
$4.15M
+56.5%
Hassan Fred
Director
9,191
0.0017%
$3.83M
+89.1%
Such Annette Louise
VP, Finance and CAO
8,478
0.0016%
$3.53M
+16.7%
Druker Brian
Director
8,391
0.0016%
$3.49M
+816.0%
Austin Wanda M
Director
8,018
0.0015%
$3.34M
ISHRAK OMAR
Director
7,486
0.0014%
$3.12M
+1,079%
Drake Michael V
Director
5,876
0.0011%
$2.45M
+1,459%
MILES AMY E
Director
5,640
0.0010%
$2.35M
+1,282%
Klotman Mary E.
Director
2,211
0.0004%
$920.72K
+12,183%
Insider
Date
Role
Action
Shares
Price
Amount
Bradway Robert A
4 Mar 2026
Chairman, CEO and President
Exercised, kept
119,782
$156.35
$18.73M
ECKERT ROBERT
10 Aug 2022
Director
Exercised, kept
20,000
$85.59
$1.71M
Bradway Robert A
18 Feb 2021
Chairman, CEO and President
Exercised, kept
73,500
$54.69
$4.02M
REESE DAVID M
16 Feb 2021
EVP, Research and Development
Exercised, kept
2,300
$54.69
$125.79K
Bradway Robert A
13 Apr 2020
Chairman, CEO and President
Exercised, kept
84,000
$58.43
$4.91M
Bradway Robert A
13 Apr 2020
Chairman, CEO and President
Exercised, kept
43,000
$58.43
$2.51M
Piacquad David
20 Nov 2019
SVP, Business Development
Exercised, kept
5,749
$156.35
$898.86K
Piacquad David
30 Nov 2018
SVP, Business Development
Exercised, kept
6,500
$54.69
$355.49K
HENDERSON REBECCA M
10 Aug 2018
Director
Exercised, kept
3,000
$63.11
$189.33K
Piacquad David
11 May 2018
SVP, Business Development
Exercised, kept
15,000
$54.71
$820.65K

What was left out

Form 4 filings counted 783
Amendments (4/A) skipped 0
Filings about a different issuer 10
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 39
Sales at will 47
Transactions with no price 0
Shares from compensation/vesting 3,401,830
Sales filed before the plan box existed 31
History held since 13 Sep 2016